Ama Journal of Ethics Physicians – Medical Marijuana and the Law
The US Court of Appeals for the Ninth Circuit recently upheld a loophole in the US law regarding medicinal marijuana and doctors’ recommendations. The court reasoned that doctors are protected by the First Amendment from being held responsible for their recommendations, even if they were made after they had left the office. Providing accurate information about the risks and benefits of medicinal marijuana is essential to a doctor-patient relationship and proper treatment.
The debate over the legality of marijuana in pregnancy is particularly pertinent given the looming opioid epidemic. While several professional associations strongly discourage use, some patients seek out marijuana for therapeutic reasons. In these cases, doctors should replace marijuana with a safer alternative. The principle of “do no harm” requires uncompromising vigilance, and doing less would neglect the well-being of an expectant mother’s potential progeny.
Charlotte Figi was referred to hundreds of doctors, who all refused to prescribe marijuana. The reason for their reluctance was Charlotte’s age, ineffectiveness, and federal law. In addition, both her pediatrician and neurologist had concerns about administering marijuana to such a young child. The alternatives seemed far worse than marijuana, and Dr. Geddy explained that marijuana was easier to administer and had less adverse side effects than alternative treatments.
Originally, she studied the immunological effects of dietary lipid manipulation, as well as how behavior impacts the development of diseases and their progression. She also focused on the legal aspects of cannabis use, and has testified before state committees in Connecticut, Pennsylvania, and Colorado. While her work in Colorado has largely focused on the law surrounding cannabis, Dr. Shackelford is a strong supporter of scientific research into the therapeutic use of cannabis.
The US Court of Appeals for the Ninth Circuit upheld the recommendation loophole, stating that “discussing medicinal marijuana’s therapeutic benefits and making recommendations” is protected speech. The court argued that physicians should not be held liable for their actions after leaving the office, and that open communication is essential to the doctor-patient relationship. The court also recognized the importance of maintaining a clear line between patient confidentiality and medical treatment.
Dr. Geddy’s parents
A recent case involving medicinal marijuana and federal prosecutors has highlighted the ethical issues surrounding the drug. The US Department of Justice recently issued a memo telling federal prosecutors to focus their efforts on identifying drug trafficking organizations rather than on individuals using marijuana for medical purposes. While many physicians have argued that marijuana is not illegal in any state, others say it has a different legal status than alcohol or tobacco.
The need for opioid substitutes is greater than ever, and the healthcare system’s role is to optimize symptom relief. However, federal law prohibits insurers from covering non-standardized products, which are inconsistent with high-quality evidence. Instead, they should partner with academics and providers to develop evidence-based decision-making processes that can result in safer patient management.
Currently, medical marijuana is only allowed in Illinois for the treatment of certain conditions. These include chronic pain, severe nausea, seizures, multiple sclerosis, and Crohn’s disease. However, you don’t have to be a licensed medical marijuana patient to grow your own cannabis. In fact, you can grow up to seven plants – but only three of them must be mature. If you’re looking to grow your own cannabis, be sure to consult with your physician first.
While there are still many hurdles for health care practitioners treating medical marijuana patients, the federal status of the plant can make the process more difficult. Because patients may not be forthcoming about their previous medications, health care providers may fail to recognize the use of medical marijuana and may prescribe harmful drugs. Additionally, medical marijuana may require health practitioners to administer or assist patients in administering the plant. This could result in adverse drug interactions, which could make the patient reliant on the practitioner’s help.
A recent study surveyed 1,544 doctors in 12 medical specialties in 48 states. It found that 56 percent of physicians support legalizing medical marijuana on a national level, while 69 percent believe that the drug has real medical benefits. Oncologists and hematologists overwhelmingly supported marijuana use, as it helps patients with cancer reduce pain, counter nausea, and stimulate appetites that are diminished by chemotherapy.
In addition to assessing the legal and ethical issues surrounding marijuana, this study also examined the attitudes of medical students toward the substance. Although medical students are increasingly educated and open-minded about cannabis, their attitudes toward the plant have changed significantly in the past three decades. However, more research needs to be done to understand the nuances of medical students’ concerns about marijuana. The general public has largely accepted marijuana as a benign drug, and many physicians believe that it can help with symptoms of debilitating illnesses.
The issue of whether medical marijuana is a valid therapy has been a source of controversy for years, but the recent decision by the US Court of Appeals for the Ninth Circuit has paved the way for new rules that allow doctors to discuss the benefits of medical marijuana with their patients. This ruling also protects physicians from liability for what they say outside the office. After all, the physician-patient relationship is crucial to receiving proper treatment.
In addition to the legal implications, the issue of prescribing marijuana can lead to revocation of medical licenses for physicians who prescribe it. In Massachusetts, many physicians have been slow to write recommendations because of the risk of losing their DEA licenses. In the meantime, the DEA threatens to suspend their licenses to prescribe controlled substances. While the issue is still in its infancy, more states are following suit, and a legal solution is within reach.
Hawai’i medical association
The Hawaii Medical Association (HMA) took a stance against the 2000 state bill that legalized the sale of medical marijuana. The HMA argues that medical marijuana should only be sold in non-smoking forms and is more acceptable for the medical profession. After all, the inhalation of raw marijuana can contain unknown co-drugs. The Hawaii Medical Association is also concerned with the misuse of prescription opioids.
Those who qualify for a medical card can purchase marijuana from dispensaries on the islands of Hawaii and other U.S. territories. The patient must possess a valid medical registration card and photo ID from their home state. They must also use the marijuana for a qualifying condition. Unlike in most other states, Hawaii does not allow recreational use of marijuana. The state has strict rules that must be followed to ensure that marijuana is safe and effective for patients.
Hawai’i state medical association
Hawaii has a long-established medical marijuana program, but the state’s laws have not been changed in years. This means that patients are not eligible for random drug testing and are not permitted to bring medical marijuana on interisland flights. Advocates accuse state law enforcement of stonewalling attempts to expand the program. But they say that the new law is a positive step toward safer society. We will continue to work for safe, legal access to medical marijuana in Hawaii.
To qualify for the program, patients must suffer from one of the qualifying illnesses. These include cancer, HIV/AIDS, glaucoma, rheumatoid arthritis, glaucoma, lupus, epilepsy, severe pain, and cachexia. Minors can qualify, but only if their parents give permission and control the dosage and frequency. Schools are also prohibited from refusing to enroll a patient because they are a caregiver.
Colorado state medical association
Before the passage of HB 1317, Colorado had considered itself an asylum for marijuana patients. This changed when voters passed Amendment 20 and made it legal for designated caregivers to grow marijuana. The amendment also banned federal funds from interfering with state-legal medical marijuana programs. As of January 1, 2018, Colorado doctors can recommend and prescribe medical marijuana to their patients for certain conditions. The new law requires physicians to note the dosage and method of ingestion. Despite the law, however, doctors must register with the Drug Enforcement Administration (DEA), which restricts the ability of doctors to prescribe Schedule I drugs. Cannabis is still classified as a Schedule I drug federally.
The medical card also requires the primary caregiver to control the acquisition, dosage, and frequency of cannabis use. The primary caregiver must also establish a confidential registry of patients for whom they recommend cannabis use. This list can be used to review physician referrals to the board of medical examiners or to investigate suspected violations of the state constitution’s article XVIII, subsection (3) or (5). These patients may have a limited number of caregivers to choose from.